United Therapeutics (UTHR) EBIT Margin (2009 - 2026)
United Therapeutics (UTHR) posted EBIT Margin of 42.23% for Q2 2026, down 3.41 percentage points from 45.64% a year earlier but up 0.54 percentage points from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) EBIT Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at United Therapeutics was 44.44%, down 2.61 percentage points year-over-year; for FY2025, it came in at 46.89%, down 0.96 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of +6.88 percentage points (FY2020 to FY2025).
- In prior years, United Therapeutics' EBIT Margin was 47.86% in FY2024 (-3.05 pp), 50.91% in FY2023 (+0.31 pp), 50.60% in FY2022 (+17.62 pp) and 32.98% in FY2021 (-7.04 pp).
- Quarterly EBIT Margin has run from a low of 35.73% in Q4 2022 to a high of 62.35% in Q1 2022 over five years.
- On a year-over-year basis, EBIT Margin has declined in each of the last three quarters, with an average year-over-year change of -1.96 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q1 2022, with a gain of 79.44 percentage points; the weakest was Q3 2024, with a drop of 7.85 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was 41.69% (Q1 2026), 45.14% (Q4 2025) and 48.59% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | United Therapeutics | 20.72 Bn | 10.22 Bn | 683.80 Mn | 42.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.23% |
| Mar 31, 2026 | 41.69% |
| Dec 31, 2025 | 45.14% |
| Sep 30, 2025 | 48.59% |
| Jun 30, 2025 | 45.64% |
| Mar 31, 2025 | 48.19% |
| Dec 31, 2024 | 48.61% |
| Sep 30, 2024 | 45.81% |
| Jun 30, 2024 | 44.75% |
| Mar 31, 2024 | 52.57% |
| Dec 31, 2023 | 42.31% |
| Sep 30, 2023 | 53.66% |
| Jun 30, 2023 | 52.54% |
| Mar 31, 2023 | 56.11% |
| Dec 31, 2022 | 35.73% |
| Sep 30, 2022 | 60.91% |
| Jun 30, 2022 | 43.22% |
| Mar 31, 2022 | 62.35% |
| Dec 31, 2021 | 40.90% |
| Sep 30, 2021 | 51.43% |
API Access
United Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();